Neutralizing Antibody Response and SARS Severity
Mei‐Shang Ho, Wei‐Ju Chen, Hour‐Young Chen, Szu-Fong Lin, Min-Chin Wang, Jiali Di, Yen‐Ta Lu, Ching‐Lung Liu, Shan‐Chwen Chang, Chung-Liang Chao, Chwan‐Chuen King, Jeng‐Min Chiou, Ih‐Jen Su, Pan‐Chyr Yang
Emerging infectious diseases, 2005
Abstract
This research paper explore the methodology and findings associated with Emerging infectious diseases. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).
- Kinetics of antibody responses in hens from chicken lines divergently selected for response to sheep red blood cells 1999
- Screening of neutralizing antibody titers against enterovirus 71 in human intravenous immunoglobulin(pH 4) 2012
- The dynamic change of chicken serum antibody after inject IgY 2012
- STUDIES ON THE ANTIBODY DISTRIBUTION OF COXSACKIE VIRUS. PART-II 1957
- Immunoglobulin replacement products in current clinical use in the United States have poor neutralizing activity against SARS-CoV-2 Omicron strains 2023
- Applied logistic regression 1990
- Linear Mixed Models for Longitudinal Data 1997
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice 2004
- Antibody‐dependent enhancement of viral infection: molecular mechanisms and <i>in vivo</i> implications 2003
- Antibody-Dependent Enhancement of Viral Infectivity 1986